tiprankstipranks
BB Biotech AG (GB:0JYO)
LSE:0JYO
UK Market
Holding GB:0JYO?
Track your performance easily

BB Biotech (0JYO) Financial Statements

3 Followers

BB Biotech Financial Overview

BB Biotech's market cap is currently ―. The company's EPS TTM is CHF2.285; its P/E ratio is ―; and it has a dividend yield of 5.26%. BB Biotech is scheduled to report earnings on February 21, 2025, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Mar 21Jun 17Mar 17
Income Statement-
Total Revenue$ -222.52M$ -298.02M$ 223.06M$ 113.08M$ 376.79M
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders$ -233.06M$ -299.86M$ 220.95M$ 103.39M$ 375.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 2.85B$ 3.12B-$ 3.36B$ 3.53B
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 334.46M$ 359.64M-$ 30.12M$ 313.67M
Stockholders Equity$ 2.52B$ 2.76B$ ―$ 3.33B$ 3.22B
Cash Flow-
Free Cash Flow$ 37.34M$ 221.08M$ -100.02M$ 319.69M$ 52.41M
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow$ -37.32M$ -223.00M$ 96.92M$ -302.45M$ -56.19M
Currency in USD

BB Biotech Earnings and Revenue History

BB Biotech Debt to Assets

BB Biotech Cash Flow

BB Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis